API
Pharmacies hit hard by pandemic slowdown
Chemist Warehouse and Priceline are reportedly asking for “massive” rent reductions, as API warns that pharmacies could close and one industry expert says some stores are severely impacted by the …
API sees return to growth
Group reports total revenue of $4 billion, up 4.1% on the prior year, excluding PBS reforms and hepatitis C medicines API has reported earnings before interest and tax of $94 …
A win for full-line wholesalers
Pharmaceutical manufacturer ditches direct distribution model for CSO wholesalers in move driven by pharmacist feedback AstraZeneca has announced it will exit its exclusive-direct distribution arrangements and return supply of its …
“Strong” position has led to investments
Despite facing PBS reform and intense competition, API reports $25 million net profit after tax and $2 billion in revenue in its half-year results for 2019 Australian Pharmaceutical Industries (API) …
The week in review
APP2019 might be over, but the pharmacy sector didn’t slow down, with a big week in industrial relations and other business matters Workers at three distribution centres for Chemist Warehouse …
It’s over for API-Sigma merger
Sigma’s Board has rejected the API proposal to take it over as not in the best interest of Sigma shareholders The non-binding indicative proposal from API to acquire all Sigma’s …
NPSA head talks potential DHL entry to CSO
Sigma and NPSA’s Mark Hooper has said he hopes for a swift resolution of the API/Sigma merger, and addressed the potential for DHL to enter the CSO Mr Hooper, president …
Sigma affirms ‘strong future’
A review initiated after losing My Chemist/Chemist Warehouse supply contract has identified over $100m per year in savings Sigma Healthcare Limited has announced a “strong outlook” after conducting a review …
CWH contract loss an ‘opportunity’
API thinks it has a better chance of merging with Sigma second-time around following PBS reforms and a changed industry landscape Last Friday Australian Pharmaceutical Industries Limited (API) announced that …
API announces proposal to merge with Sigma
Under the scheme, API shareholders would own approximately 63% of the combined entity with Sigma shareholders owning the remaining 37% Australian Pharmaceutical Industries Limited (API) has today lodged a substantial …
API delivers on guidance despite ‘difficult conditions’
PBS changes and exclusive direct distribution wiped more than $10 million in gross profit, according to FY18 results Australian Pharmaceutical Industries (API) has reported mixed results in its financial year …
API: Exclusive supply still a ‘very big issue’
The CEO of one of Australia’s leading pharmaceutical distributors says he wishes a solution had been organised “yesterday” Exclusive supply of medicines is still a “very big issue”, says Richard …